Cargando…

Recipient Hyperbilirubinemia May Reduce Ischemia-Reperfusion Injury but Fails to Improve Outcome in Clinical Liver Transplantation

Background. Exogenous bilirubin may reduce experimental ischemia-reperfusion injury (IRI) due to its antioxidant properties. We studied if early graft exposure to high bilirubin levels in the recipient affects the early IRI and outcomes after liver transplantation (LTx). Methods. In 427 LTx patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oltean, Mihai, Barrenäs, Christian, Martins, Paulo Ney, Herlenius, Gustaf, Gustafsson, Bengt, Friman, Styrbjörn, Bennet, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893452/ https://www.ncbi.nlm.nih.gov/pubmed/27313607 http://dx.doi.org/10.1155/2016/6964856

Ejemplares similares

Liver Graft Proteomics Reveals Potential Incipient Mechanisms behind Early Renal Dysfunction after Liver Transplantation
por: Norén, Åsa, et al.
Publicado: (2022)

Endoscopic ultrasound in the monitoring of the intestinal allograft
por: Oltean, Mihai, et al.
Publicado: (2022)

Initial Experience of Video Capsule Endoscopy After Intestinal Transplantation
por: Varkey, Jonas, et al.
Publicado: (2016)

A Randomized Multicenter Study Comparing a Tacrolimus-Based Protocol with and without Steroids in HCV-Positive Liver Allograft Recipients
por: Neumann, Ulf, et al.
Publicado: (2012)

COVID‐19 in lung transplant recipients: an overview of the Swedish national experience
por: Magnusson, Jesper M., et al.
Publicado: (2021)

Hemorheological and Microcirculatory Factors in Liver Ischemia-Reperfusion Injury—An Update on Pathophysiology, Molecular Mechanisms and Protective Strategies
por: Nemeth, Norbert, et al.
Publicado: (2021)

COVID-19 in solid organ transplant recipients: A national cohort study from Sweden
por: Søfteland, John M., et al.
Publicado: (2021)

Oral Supplementation of Glucosamine Fails to Alleviate Acute Kidney Injury in Renal Ischemia-Reperfusion Damage
por: Johnsen, Marc, et al.
Publicado: (2016)

Long-term Course of Kidney Function in Uterus Transplant Recipients Under Treatment With Tacrolimus and After Transplantectomy: Results of the First Clinical Cohort
por: Ekberg, Jana, et al.
Publicado: (2023)

Neonatal hyperbilirubinemia
por: Ben, Matteo Dal, et al.
Publicado: (2014)

Hyperoxia after cardiac arrest may not increase ischemia-reperfusion injury
por: Hoedemaekers, Cornelia W, et al.
Publicado: (2011)

Calcineurin Inhibitors in Lung Donors to Attenuate Ischemia–Reperfusion Injury in Recipients: Next Steps?
por: Rozenberg, Dmitry, et al.
Publicado: (2022)

A marginal liver graft with hyperbilirubinemia transplanted successfully by ischemia-free liver transplantation
por: Huang, Changjun, et al.
Publicado: (2021)

Hyperbilirubinemia and Pelvicaliceal Dilatation
por: Wiwanitkit, Viroj
Publicado: (2012)

Hyperoxic preconditioning fails to confer additional protection against ischemia-reperfusion injury in acute diabetic rat heart
por: Pourkhalili, Khalil, et al.
Publicado: (2012)

Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival
por: Mantel, Hendrik T. J., et al.
Publicado: (2016)

Bioelectrical Impedance May Predict Cell Viability During Ischemia and Reperfusion in Rat Liver
por: Cui, Mei Lan, et al.
Publicado: (2010)

Antioxidant vitamins and hyperbilirubinemia in neonates
por: Abdul-Razzak, Khalid K., et al.
Publicado: (2007)

Hyperbilirubinemia in normal healthy donors
por: Arora, Veena, et al.
Publicado: (2009)

Hyperbilirubinemia following lenalidomide administration
por: Azmy, Veronica, et al.
Publicado: (2018)

Severe Lenalidomide-Associated Hyperbilirubinemia
por: Gildea, Daniel T, et al.
Publicado: (2023)

Long-term, Prolonged-release Tacrolimus-based Immunosuppression in De Novo Liver Transplant Recipients: 5-year Prospective Follow-up of Patients in the DIAMOND Study
por: Friman, Styrbjörn, et al.
Publicado: (2021)

High-Dose Polymerized Hemoglobin Fails to Alleviate Cardiac Ischemia/Reperfusion Injury due to Induction of Oxidative Damage in Coronary Artery
por: Yang, Qian, et al.
Publicado: (2015)

Mitophagy in Cerebral Ischemia and Ischemia/Reperfusion Injury
por: Shen, Luoan, et al.
Publicado: (2021)

Protein kinase C in porcine retinal arteries and neuroretina following retinal ischemia-reperfusion
por: Gesslein, Bodil, et al.
Publicado: (2009)

Registry reports in COVID-19 patients: juggling with big data, poor data, and no data
por: Søfteland, John Mackay, et al.
Publicado: (2020)

Formononetin may protect aged hearts from ischemia/reperfusion damage by enhancing autophagic degradation
por: Huang, Zhengxin, et al.
Publicado: (2018)

CLCF1 is up-regulated in renal ischemia reperfusion injury and may associate with FOXO3
por: Wang, Sixu, et al.
Publicado: (2022)

Clinical significance of hyperbilirubinemia in the CASTLE study
por: Uy, J, et al.
Publicado: (2010)

An Unusual Case of Rapidly Progressive Hyperbilirubinemia
por: Thornton, Kimberly M., et al.
Publicado: (2013)

Neurobehavior of term neonates with neonatal hyperbilirubinemia
por: Babu, Thirunavukkarasu Arun, et al.
Publicado: (2013)

Hyperbilirubinemia exaggerates endotoxin-induced hypothermia
por: Pakai, Eszter, et al.
Publicado: (2015)

Analysis of hyperbilirubinemia in patients with Kawasaki disease
por: Cheng, Fang, et al.
Publicado: (2020)

Challenges of phototherapy for neonatal hyperbilirubinemia (Review)
por: Wang, Juan, et al.
Publicado: (2021)

Hyperbilirubinemia and Hyponatremia as Predictors of Complicated Appendicitis
por: Shuaib, Abdullah, et al.
Publicado: (2022)

The novel nitric oxide donor PDNO attenuates ovine ischemia-reperfusion induced renal failure
por: Nilsson, Kristofer F., et al.
Publicado: (2017)

HDACi Valproic Acid (VPA) and Suberoylanilide Hydroxamic Acid (SAHA) Delay but Fail to Protect against Warm Hepatic Ischemia-Reperfusion Injury
por: Ruess, Dietrich A., et al.
Publicado: (2016)

Corrigendum to “High-Dose Polymerized Hemoglobin Fails to Alleviate Cardiac Ischemia/Reperfusion Injury due to Induction of Oxidative Damage in Coronary Artery”
por: Yang, Qian, et al.
Publicado: (2019)

Ischemia-Reperfusion Injury and Anesthesia
por: Zarbock, Alexander, et al.
Publicado: (2014)

Ceramide and Ischemia/Reperfusion Injury
por: He, Xingxuan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tsb3nb1devn614cqp4hpgajkd3